Speaker Details

Steven Daniel Daveluy, MD, FAAD

SESSIONS

U009 In Office Surgical Techniques for the Treatment of Moderate to Severe Hidradenitis Suppurativa (HS)

Mar 27, 2026 • 7:30 AM - 8:30 AM • Mile High 4D

C002 Conquer the Boards: Core Exam & Review

Mar 27, 2026 • 9:00 AM - 12:00 PM • Bluebird 2A

C006 Conquer the Boards: Applied Exam & Review

Mar 27, 2026 • 1:00 PM - 4:00 PM • Bluebird 2A

F029 DataDerm Discoveries: How Registry Data Are Powering Real-World Research, AI Applications, and Inspiring Your Next Study

Mar 28, 2026 • 9:00 AM - 11:00 AM • Bluebird 2E

F039 Dietary Triggers and Modifications of Common Dermatologic Conditions: An Evidence Based Approach

Mar 28, 2026 • 1:00 PM - 3:00 PM • Four Seasons 4

U071 Advancing HS Diagnosis with Artificial Intelligence: A Multi-Phased Collaborative Approach

Mar 29, 2026 • 8:00 AM - 9:00 AM • Mile High 2A

F058 How to Approach Challenges in Hidradenitis Suppurativa Management: Strategies to Optimize Use of HS Therapies

Mar 29, 2026 • 1:00 PM - 3:00 PM • Bluebird 1B

U077 Data-Driven Dermatology: Mastering MIPS and Improving Practice Quality

Mar 29, 2026 • 4:30 PM - 5:30 PM • Mile High 3A

S052 LGBTQ/SGM Health in Dermatology: Essentials and Updates

Mar 30, 2026 • 9:00 AM - 12:00 PM • Mile High 3A

DISCLOSURES

AbbVie – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Incyte – Advisory Board(Honoraria); Insmed – Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Investigator(Grants/Research Funding); Novartis – Speaker(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); UCB – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Honoraria);